About
Phage-display Antibody Discovery, ADCs
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodySan Diego & Southern California
Team (12)
Allen Albright
Allen Albright, PHD
MBrace Therapeutics
team_member
Bob More
Bob More
MBrace Therapeutics
team_member
Carolyn Ng
Carolyn Ng, PHD
MBrace Therapeutics
team_member
Chris LeMasters
Chris LeMasters
MBrace Therapeutics
team_member
Isan Chen
Isan Chen, MD
MBrace Therapeutics
team_member
Jay Stamatis
Jay Stamatis
MBrace Therapeutics
team_member
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
280
By Phase
PHASE1/PHASE2: 2
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07145255Lead Sponsor
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
PHASE1/PHASE2Not yet recruiting
150 participants
Started: Sep 30, 2025 · Completed: Dec 30, 2029
NCT06014658Lead Sponsor
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
PHASE1/PHASE2Recruiting
130 participants
Started: Nov 7, 2023 · Completed: Nov 30, 2026
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...